Structural and functional insights into the evolution of SARS-CoV-2 KP.3.1.1 spike protein.

Publication date: Jul 04, 2025

The JN. 1-sublineage KP. 3.1. 1 recently emerged as the globally prevalent SARS-CoV-2 variant, demonstrating increased infectivity and antibody escape. We investigate how mutations and a deletion in the KP. 3.1. 1 spike protein (S) affect hACE2 binding and antibody escape. Mass spectrometry confirms a new glycan site at residue N30 that alters the glycoforms at neighboring N61. Cryoelectron microscopy (cryo-EM) structures show that the N30 glycan and rearrangement of adjacent residues do not significantly change the overall spike structure, up-down ratio of receptor-binding domains (RBDs), or hACE2 binding. Furthermore, a KP. 3.1. 1 S with hACE2 structure further confirms an epistatic effect between F456L and Q493E on hACE2 binding. Our analysis shows that SARS-CoV-2 variants that emerged after late 2023 are now incorporating reversions to residues found in other sarbecoviruses, including the N30 glycan, Q493E, and others. Overall, these results inform on the structural and functional consequences of the KP. 3.1. 1 mutations, the current SARS-CoV-2 evolutionary trajectory, and immune evasion.

Open Access PDF

Concepts Keywords
Antibody antibody evasion
Cryoelectron COVID-19
F456l CP: Immunology
Sarbecoviruses hACE2
Spike KP.3.1.1
mutational landscape
N-glycosylation
receptor binding affinity
SARS-CoV-2
spike conformational change

Semantics

Type Source Name
disease IDO protein
disease IDO infectivity
disease IDO site
drug DRUGBANK Amino acids
disease MESH infection
pathway REACTOME Reproduction
disease IDO host
disease MESH Influenza
drug DRUGBANK Mannose
drug DRUGBANK Trestolone
drug DRUGBANK Hyaluronic acid
drug DRUGBANK Cysteamine
disease IDO assay
disease MESH dissociation
disease MESH COVID-19

Original Article

(Visited 2 times, 1 visits today)